FDA Approves Pilocarpine Hydrochloride Ophthalmic Solution to Treat Presbyopia
Pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi, Orasis Pharmaceuticals) has received FDA approval for the treatment of presbyopia in adults. Presbyopia is the loss of the ability to focus on nearby objects and is caused by the natural aging process. A press release from Orasis states that 128 million people in the United States are affected …